Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amarin Corp Plc\uk (AMRN) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Amarin Corp Plc\uk. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 897448.
Total stock buying since 2015: $797,679.
Total stock sales since 2015: $169,178,057.
Total stock option exercises since 2015: $34,014,056.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 0 | $0 | 0 | $0 | 482,782 | $0 |
2024 | 174,426 | $118,124 | 0 | $0 | 248,199 | $0 |
2023 | 300,000 | $312,600 | 34,131 | $26,963 | 524,826 | $0 |
2022 | 55,000 | $92,730 | 0 | $0 | 380,268 | $0 |
2021 | 12,000 | $39,000 | 759,357 | $5,760,157 | 2,316,971 | $1,484,803 |
2020 | 25,000 | $121,525 | 1,067,405 | $11,798,815 | 2,478,317 | $3,909,999 |
2019 | 0 | $0 | 5,162,241 | $96,673,233 | 4,759,898 | $16,904,780 |
2018 | 0 | $0 | 4,303,254 | $53,094,573 | 4,804,975 | $11,714,474 |
2017 | 10,000 | $32,450 | 371,390 | $1,452,226 | 1,201,460 | $0 |
2016 | 25,000 | $34,250 | 122,358 | $372,090 | 1,057,376 | $0 |
2015 | 20,000 | $47,000 | 0 | $0 | 470,876 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-05-29 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 3,056 | .00 | 0 |
2020-05-29 | Thero John F (President and CEO) | Option Ex | 13,472 | .00 | 0 |
2020-05-01 | Berg Aaron (CHIEF COMMERCIAL OFFICER) | Option Ex | 26,000 | .00 | 0 |
2020-04-30 | Berg Aaron (CHIEF COMMERCIAL OFFICER) | Option Ex | 3,056 | .00 | 0 |
2020-04-30 | Kalb Michael Wayne (SVP and CFO) | Option Ex | 3,056 | .00 | 0 |
2020-04-30 | Kennedy Joseph T (General Counsel) | Option Ex | 3,610 | .00 | 0 |
2020-04-30 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 3,056 | .00 | 0 |
2020-04-30 | Thero John F (President and CEO) | Option Ex | 13,472 | .00 | 0 |
2020-03-31 | Berg Aaron (CHIEF COMMERCIAL OFFICER) | Option Ex | 3,056 | .00 | 0 |
2020-03-31 | Kalb Michael Wayne (SVP and CFO) | Option Ex | 3,056 | .00 | 0 |
2020-03-31 | Kennedy Joseph T (General Counsel) | Option Ex | 3,612 | .00 | 0 |
2020-03-31 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 3,056 | .00 | 0 |
2020-03-31 | Thero John F (President and CEO) | Option Ex | 13,472 | .00 | 0 |
2020-03-04 | Thero John F (President and CEO) | Sale | 200,000 | 15.99 | 3,198,800 |
2020-02-28 | Berg Aaron (CHIEF COMMERCIAL OFFICER) | Option Ex | 3,056 | .00 | 0 |
2020-02-28 | Kalb Michael Wayne (SVP and CFO) | Option Ex | 3,056 | .00 | 0 |
2020-02-28 | Kennedy Joseph T (General Counsel) | Option Ex | 3,612 | .00 | 0 |
2020-02-28 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 3,056 | .00 | 0 |
2020-02-28 | Thero John F (President and CEO) | Option Ex | 13,472 | .00 | 0 |
2020-02-25 | Berg Aaron (CHIEF COMMERCIAL OFFICER) | Option Ex | 51,948 | .00 | 0 |
2020-02-25 | Kalb Michael Wayne (SVP and CFO) | Option Ex | 51,948 | .00 | 0 |
2020-02-25 | Kennedy Joseph T (General Counsel) | Option Ex | 61,394 | .00 | 0 |
2020-02-25 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 51,948 | .00 | 0 |
2020-02-25 | Thero John F (President and CEO) | Option Ex | 229,030 | .00 | 0 |
2020-01-31 | Berg Aaron (CHIEF COMMERCIAL OFFICER) | Option Ex | 41,734 | .00 | 0 |
2020-01-31 | Kalb Michael Wayne (SVP and CFO) | Option Ex | 67,734 | .00 | 0 |
2020-01-31 | Kennedy Joseph T (General Counsel) | Option Ex | 74,734 | .00 | 0 |
2020-01-31 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 67,734 | .00 | 0 |
2020-01-31 | Thero John F (President and CEO) | Option Ex | 315,367 | .00 | 0 |
2020-01-03 | Zakrzewski Joseph S (Director) | Sale | 300,000 | 20.94 | 6,282,900 |
2020-01-03 | Zakrzewski Joseph S (Director) | Option Ex | 300,000 | 3.40 | 1,020,000 |
2019-12-16 | Berg Aaron (CHIEF COMMERCIAL OFFICER) | Sale | 43,253 | 25.46 | 1,101,351 |
2019-12-16 | Berg Aaron (CHIEF COMMERCIAL OFFICER) | Option Ex | 43,253 | 12.60 | 544,987 |
2019-12-16 | Kalb Michael Wayne (SVP and CFO) | Sale | 25,000 | 24.34 | 608,475 |
2019-12-16 | Kalb Michael Wayne (SVP and CFO) | Option Ex | 25,000 | 2.19 | 54,750 |
2019-12-16 | Zakrzewski Joseph S (Director) | Sale | 100,000 | 25.83 | 2,583,400 |
2019-12-16 | Zakrzewski Joseph S (Director) | Option Ex | 100,000 | 9.00 | 900,000 |
2019-11-19 | Thero John F (President and CEO) | Sale | 274,454 | 22.65 | 6,217,480 |
2019-11-12 | Ekman Lars (Director) | Sale | 38,600 | 19.35 | 746,755 |
2019-11-12 | Ekman Lars (Director) | Option Ex | 38,600 | 14.40 | 555,840 |
2019-11-11 | Thero John F (President and CEO) | Sale | 475,546 | 17.47 | 8,305,886 |
2019-11-05 | Ekman Lars (Director) | Sale | 6,400 | 18.00 | 115,232 |
2019-11-05 | Ekman Lars (Director) | Option Ex | 6,400 | 14.40 | 92,160 |
2019-10-28 | Thero John F (President and CEO) | Option Ex | 11,601 | 2.50 | 29,002 |
2019-09-03 | Ekman Lars (Director) | Sale | 91,016 | 15.01 | 1,365,695 |
2019-09-03 | Ekman Lars (Director) | Option Ex | 91,016 | 3.95 | 359,513 |
2019-08-21 | Thero John F (President and CEO) | Option Ex | 191,997 | 1.85 | 355,770 |
2019-07-11 | Stack David M (Director) | Sale | 51,991 | 22.28 | 1,158,359 |
2019-07-11 | Stack David M (Director) | Option Ex | 51,991 | 2.35 | 121,918 |
2019-07-05 | Zakrzewski Joseph S (Director) | Sale | 100,000 | 23.82 | 2,381,600 |
2019-07-05 | Zakrzewski Joseph S (Director) | Option Ex | 100,000 | 9.00 | 900,000 |
2019-07-03 | Berg Aaron (CHIEF COMMERCIAL OFFICER) | Sale | 29,250 | 22.64 | 662,249 |
2019-07-03 | Berg Aaron (CHIEF COMMERCIAL OFFICER) | Option Ex | 29,250 | 2.80 | 81,900 |
2019-07-02 | Berg Aaron (CHIEF COMMERCIAL OFFICER) | Sale | 69,564 | 20.94 | 1,456,739 |
2019-07-02 | Berg Aaron (CHIEF COMMERCIAL OFFICER) | Option Ex | 69,564 | 2.50 | 173,910 |
2019-07-01 | Kalb Michael Wayne (SVP and CFO) | Sale | 50,000 | 19.66 | 983,250 |
2019-07-01 | Kalb Michael Wayne (SVP and CFO) | Option Ex | 50,000 | 2.19 | 109,500 |
2019-07-01 | Kennedy Joseph T (General Counsel) | Sale | 54,186 | 19.52 | 1,057,927 |
2019-07-01 | Kennedy Joseph T (General Counsel) | Option Ex | 27,244 | 2.66 | 72,523 |
2019-06-30 | Kennedy Joseph T (General Counsel) | Option Ex | 53,437 | .00 | 0 |
2019-06-30 | Thero John F (President and CEO) | Option Ex | 37,500 | .00 | 0 |
2019-06-24 | Berg Aaron (CHIEF COMMERCIAL OFFICER) | Sale | 113,195 | 18.59 | 2,104,521 |
2019-06-24 | Berg Aaron (CHIEF COMMERCIAL OFFICER) | Option Ex | 100,000 | 2.50 | 250,000 |
2019-06-18 | Zakrzewski Joseph S (Director) | Sale | 100,000 | 19.02 | 1,902,100 |
2019-06-18 | Zakrzewski Joseph S (Director) | Option Ex | 100,000 | 3.40 | 340,000 |
2019-05-31 | Kennedy Joseph T (General Counsel) | Sale | 27,229 | 17.92 | 488,052 |
2019-05-31 | Kennedy Joseph T (General Counsel) | Option Ex | 27,229 | 2.66 | 72,483 |
2019-05-29 | Stack David M (Director) | Sale | 33,799 | 18.45 | 623,523 |
2019-05-29 | Stack David M (Director) | Option Ex | 33,799 | 3.21 | 108,494 |
2019-05-17 | Stack David M (Director) | Sale | 13,174 | 18.00 | 237,145 |
2019-05-17 | Stack David M (Director) | Option Ex | 13,174 | 3.21 | 42,288 |
2019-05-01 | Berg Aaron (CHIEF COMMERCIAL OFFICER) | Option Ex | 26,000 | .00 | 0 |
2019-04-30 | Kennedy Joseph T (General Counsel) | Sale | 27,230 | 18.69 | 508,847 |
2019-04-30 | Kennedy Joseph T (General Counsel) | Option Ex | 27,230 | 2.66 | 72,486 |
2019-04-30 | Ketchum Steven B (Chief Scientific Officer) | Sale | 9,541 | 18.67 | 178,111 |
2019-04-30 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 9,541 | 2.28 | 21,782 |
2019-04-01 | Kennedy Joseph T (General Counsel) | Sale | 54,172 | 20.42 | 1,105,975 |
2019-04-01 | Kennedy Joseph T (General Counsel) | Option Ex | 27,230 | 2.66 | 72,486 |
2019-04-01 | Ketchum Steven B (Chief Scientific Officer) | Sale | 9,542 | 20.41 | 194,799 |
2019-04-01 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 9,542 | 2.28 | 21,784 |
2019-03-31 | Kennedy Joseph T (General Counsel) | Option Ex | 53,437 | .00 | 0 |
2019-03-31 | Thero John F (President and CEO) | Option Ex | 37,500 | .00 | 0 |
2019-03-04 | Ekman Lars (Director) | Sale | 135,377 | 21.44 | 2,901,941 |
2019-03-04 | Ekman Lars (Director) | Option Ex | 135,377 | 1.99 | 269,806 |
2019-03-04 | Thero John F (President and CEO) | Sale | 250,000 | 21.43 | 5,357,250 |
2019-03-01 | Kalb Michael Wayne (SVP and CFO) | Sale | 100,000 | 21.84 | 2,184,300 |
2019-03-01 | Kalb Michael Wayne (SVP and CFO) | Option Ex | 100,000 | 2.98 | 298,000 |
2019-03-01 | Ketchum Steven B (Chief Scientific Officer) | Sale | 46,000 | 21.89 | 1,007,078 |
2019-03-01 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 46,000 | 2.50 | 115,000 |
2019-02-28 | Kennedy Joseph T (General Counsel) | Sale | 27,231 | 20.72 | 564,171 |
2019-02-28 | Kennedy Joseph T (General Counsel) | Option Ex | 27,231 | 2.66 | 72,488 |
2019-02-28 | Ketchum Steven B (Chief Scientific Officer) | Sale | 9,543 | 20.67 | 197,253 |
2019-02-28 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 9,543 | 2.28 | 21,786 |
2019-02-22 | Kalb Michael Wayne (SVP and CFO) | Sale | 50,000 | 18.97 | 948,500 |
2019-02-22 | Kalb Michael Wayne (SVP and CFO) | Option Ex | 50,000 | 2.95 | 147,500 |
2019-02-22 | Peterson Kristine (Director) | Sale | 163,500 | 20.02 | 3,274,087 |
2019-02-22 | Peterson Kristine (Director) | Option Ex | 163,500 | 7.88 | 1,288,870 |
2019-02-22 | Zakrzewski Joseph S (Director) | Sale | 180,625 | 19.90 | 3,594,437 |
2019-02-22 | Zakrzewski Joseph S (Director) | Option Ex | 180,625 | 8.48 | 1,531,700 |
2019-02-22 | Van Heek G Jan (Director) | Sale | 203,382 | 20.02 | 4,071,504 |
2019-02-22 | Van Heek G Jan (Director) | Option Ex | 192,347 | 4.87 | 937,306 |
2019-02-15 | Kalb Michael Wayne (SVP and CFO) | Sale | 25,000 | 17.58 | 439,525 |
2019-02-01 | Ketchum Steven B (Chief Scientific Officer) | Sale | 27,989 | 17.06 | 477,492 |
2019-01-31 | Kalb Michael Wayne (SVP and CFO) | Option Ex | 55,000 | .00 | 0 |
2019-01-31 | Kennedy Joseph T (General Counsel) | Sale | 42,624 | 17.49 | 745,451 |
2019-01-31 | Kennedy Joseph T (General Counsel) | Option Ex | 117,846 | 1.46 | 171,937 |
2019-01-31 | Ketchum Steven B (Chief Scientific Officer) | Sale | 9,541 | 17.49 | 166,872 |
2019-01-31 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 91,207 | 1.14 | 104,158 |
2019-01-31 | Thero John F (President and CEO) | Option Ex | 363,334 | .00 | 0 |
2019-01-24 | Kennedy Joseph T (General Counsel) | Sale | 609,115 | 17.66 | 10,754,534 |
2019-01-24 | Kennedy Joseph T (General Counsel) | Option Ex | 391,181 | 3.00 | 1,174,716 |
2019-01-23 | Kennedy Joseph T (General Counsel) | Sale | 255,779 | 17.95 | 4,591,233 |
2019-01-23 | Kennedy Joseph T (General Counsel) | Option Ex | 255,779 | 7.77 | 1,987,402 |
2019-01-22 | Kennedy Joseph T (General Counsel) | Sale | 175,300 | 17.92 | 3,141,901 |
2019-01-22 | Kennedy Joseph T (General Counsel) | Option Ex | 175,300 | 4.37 | 765,535 |
2019-01-11 | Kennedy Joseph T (General Counsel) | Sale | 3,173 | 18.92 | 60,033 |
2019-01-11 | Kennedy Joseph T (General Counsel) | Option Ex | 3,173 | 2.95 | 9,360 |
2019-01-10 | Ekman Lars (Director) | Sale | 140,416 | 16.99 | 2,385,948 |
2019-01-10 | Ekman Lars (Director) | Option Ex | 100,416 | 1.03 | 103,428 |
2019-01-10 | Zakrzewski Joseph S (Director) | Sale | 200,000 | 16.98 | 3,396,400 |
2019-01-10 | Zakrzewski Joseph S (Director) | Option Ex | 200,000 | 3.40 | 680,000 |
2019-01-10 | Stack David M (Director) | Sale | 125,504 | 18.00 | 2,259,072 |
2019-01-10 | Stack David M (Director) | Option Ex | 125,504 | 4.14 | 519,837 |
2019-01-09 | Kalb Michael Wayne (SVP and CFO) | Sale | 200,000 | 15.26 | 3,051,000 |
2019-01-09 | Kalb Michael Wayne (SVP and CFO) | Option Ex | 200,000 | 2.19 | 438,000 |
2019-01-02 | Zakrzewski Joseph S (Director) | Sale | 385,000 | 13.03 | 5,015,780 |
2019-01-02 | Zakrzewski Joseph S (Director) | Option Ex | 385,000 | 2.38 | 914,375 |
2018-12-31 | Kennedy Joseph T (General Counsel) | Sale | 26,943 | 13.49 | 363,541 |
2018-12-31 | Kennedy Joseph T (General Counsel) | Option Ex | 53,438 | .00 | 0 |
2018-12-31 | Ketchum Steven B (Chief Scientific Officer) | Sale | 17,041 | 13.51 | 230,206 |
2018-12-31 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 17,041 | 2.37 | 40,387 |
2018-12-31 | Thero John F (President and CEO) | Option Ex | 37,500 | .00 | 0 |
2018-12-28 | Zakrzewski Joseph S (Director) | Sale | 141,500 | 13.19 | 1,866,668 |
2018-11-30 | Kennedy Joseph T (General Counsel) | Sale | 23,306 | 17.81 | 415,009 |
2018-11-30 | Kennedy Joseph T (General Counsel) | Option Ex | 23,306 | 1.64 | 38,221 |
2018-11-30 | Ketchum Steven B (Chief Scientific Officer) | Sale | 17,042 | 17.79 | 303,177 |
2018-11-30 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 17,042 | 2.37 | 40,389 |
2018-11-12 | Thero John F (President and CEO) | Sale | 607,611 | 19.38 | 11,773,678 |
2018-11-12 | Thero John F (President and CEO) | Option Ex | 407,611 | 1.35 | 550,274 |
2018-10-31 | Kennedy Joseph T (General Counsel) | Sale | 23,307 | 21.05 | 490,495 |
2018-10-31 | Kennedy Joseph T (General Counsel) | Option Ex | 23,307 | 1.64 | 38,223 |
2018-10-31 | Ketchum Steven B (Chief Scientific Officer) | Sale | 17,042 | 21.06 | 358,853 |
2018-10-31 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 17,042 | 2.37 | 40,389 |
2018-10-01 | Kennedy Joseph T (General Counsel) | Sale | 50,249 | 17.26 | 867,398 |
2018-10-01 | Kennedy Joseph T (General Counsel) | Option Ex | 23,306 | 1.64 | 38,221 |
2018-10-01 | Ketchum Steven B (Chief Scientific Officer) | Sale | 116,604 | 17.20 | 2,005,588 |
2018-10-01 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 116,604 | 3.44 | 400,767 |
2018-09-30 | Kennedy Joseph T (General Counsel) | Option Ex | 53,438 | .00 | 0 |
2018-09-30 | Thero John F (President and CEO) | Option Ex | 37,500 | .00 | 0 |
2018-09-28 | Ketchum Steven B (Chief Scientific Officer) | Sale | 200,000 | 15.50 | 3,100,000 |
2018-09-28 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 200,000 | 8.77 | 1,754,000 |
2018-09-25 | Ketchum Steven B (Chief Scientific Officer) | Sale | 200,000 | 13.50 | 2,700,000 |
2018-09-25 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 200,000 | 8.77 | 1,754,000 |
2018-09-24 | Kalb Michael Wayne (SVP and CFO) | Sale | 150,000 | 10.44 | 1,565,550 |
2018-09-24 | Kalb Michael Wayne (SVP and CFO) | Option Ex | 150,000 | 2.19 | 328,500 |
2018-09-24 | Kennedy Joseph T (General Counsel) | Sale | 1,079,706 | 11.19 | 12,076,511 |
2018-09-24 | Kennedy Joseph T (General Counsel) | Option Ex | 1,079,706 | 1.74 | 1,878,688 |
2018-09-24 | Zakrzewski Joseph S (Director) | Sale | 500,000 | 11.24 | 5,618,500 |
2018-09-24 | Zakrzewski Joseph S (Director) | Option Ex | 500,000 | 3.40 | 1,700,000 |
2018-09-24 | Ketchum Steven B (Chief Scientific Officer) | Sale | 679,241 | 10.99 | 7,466,896 |
2018-09-24 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 620,065 | 4.10 | 2,544,126 |
2018-06-30 | Thero John F (President and CEO) | Option Ex | 37,500 | .00 | 0 |
2018-04-03 | Kennedy Joseph T (General Counsel) | Sale | 19,042 | 2.89 | 55,050 |
2018-04-02 | Kennedy Joseph T (General Counsel) | Sale | 7,900 | 2.91 | 23,020 |
2018-03-31 | Kennedy Joseph T (General Counsel) | Option Ex | 53,437 | .00 | 0 |
2018-03-31 | Thero John F (President and CEO) | Option Ex | 37,500 | .00 | 0 |
2018-01-31 | Kalb Michael Wayne (SVP and CFO) | Option Ex | 29,000 | .00 | 0 |
2018-01-31 | Kennedy Joseph T (General Counsel) | Sale | 44,857 | 3.73 | 167,406 |
2018-01-31 | Kennedy Joseph T (General Counsel) | Option Ex | 123,604 | .00 | 0 |
2018-01-31 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 116,604 | .00 | 0 |
2018-01-31 | Thero John F (President and CEO) | Option Ex | 499,667 | .00 | 0 |
2018-01-23 | Ketchum Steven B (Chief Scientific Officer) | Sale | 135,205 | 4.41 | 596,389 |
2018-01-23 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 135,205 | 2.04 | 275,818 |
2018-01-17 | Kennedy Joseph T (General Counsel) | Sale | 31,519 | 4.03 | 127,021 |
2018-01-16 | Kennedy Joseph T (General Counsel) | Sale | 10,000 | 4.13 | 41,300 |
2018-01-12 | Kennedy Joseph T (General Counsel) | Sale | 9,587 | 4.29 | 41,128 |
2018-01-11 | Ketchum Steven B (Chief Scientific Officer) | Sale | 2,612 | 4.40 | 11,492 |
2018-01-11 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 2,612 | 2.04 | 5,328 |
2018-01-05 | Ketchum Steven B (Chief Scientific Officer) | Sale | 64,683 | 4.40 | 284,605 |
2018-01-05 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 64,683 | 2.04 | 131,953 |
2018-01-02 | Ketchum Steven B (Chief Scientific Officer) | Sale | 128,257 | 4.25 | 545,092 |
2018-01-02 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 128,257 | 1.21 | 155,190 |
2017-12-31 | Kennedy Joseph T (General Counsel) | Option Ex | 53,438 | .00 | 0 |
2017-12-31 | Thero John F (President and CEO) | Option Ex | 37,500 | .00 | 0 |
2017-11-30 | Thero John F (President and CEO) | Buy | 10,000 | 3.25 | 32,450 |
2017-10-05 | Ketchum Steven B (Chief Scientific Officer) | Sale | 63,479 | 3.48 | 221,224 |
2017-09-30 | Kennedy Joseph T (General Counsel) | Option Ex | 53,438 | .00 | 0 |
2017-09-30 | Thero John F (President and CEO) | Option Ex | 37,500 | .00 | 0 |
2017-07-03 | Kennedy Joseph T (General Counsel) | Sale | 51,104 | 4.09 | 209,168 |
2017-06-30 | Kennedy Joseph T (General Counsel) | Sale | 105,039 | 3.98 | 417,950 |
2017-06-30 | Kennedy Joseph T (General Counsel) | Option Ex | 53,437 | .00 | 0 |
2017-06-30 | Thero John F (President and CEO) | Option Ex | 37,500 | .00 | 0 |
2017-06-29 | Kennedy Joseph T (General Counsel) | Sale | 151,768 | 3.98 | 603,884 |
2017-03-31 | Kennedy Joseph T (General Counsel) | Option Ex | 53,437 | .00 | 0 |
2017-03-31 | Thero John F (President and CEO) | Option Ex | 37,500 | .00 | 0 |
2017-01-31 | Kennedy Joseph T (General Counsel) | Option Ex | 144,105 | .00 | 0 |
2017-01-31 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 144,105 | .00 | 0 |
2017-01-31 | Thero John F (President and CEO) | Option Ex | 549,500 | .00 | 0 |
2016-12-31 | Kennedy Joseph T (General Counsel) | Option Ex | 53,438 | .00 | 0 |
2016-12-31 | Thero John F (President and CEO) | Option Ex | 37,500 | .00 | 0 |
2016-11-09 | Kennedy Joseph T (General Counsel) | Sale | 122,358 | 3.04 | 372,090 |
2016-09-30 | Kennedy Joseph T (General Counsel) | Option Ex | 53,438 | .00 | 0 |
2016-09-30 | Thero John F (President and CEO) | Option Ex | 37,500 | .00 | 0 |
2016-06-30 | Kennedy Joseph T (General Counsel) | Option Ex | 53,437 | .00 | 0 |
2016-06-30 | Thero John F (President and CEO) | Option Ex | 37,500 | .00 | 0 |
2016-03-31 | Kennedy Joseph T (General Counsel) | Option Ex | 53,437 | .00 | 0 |
2016-03-31 | Thero John F (President and CEO) | Option Ex | 37,500 | .00 | 0 |
2016-02-01 | Thero John F (President and CEO) | Buy | 25,000 | 1.37 | 34,250 |
2016-01-31 | Farrell Michael James (VP, Finance) | Option Ex | 29,250 | .00 | 0 |
2016-01-31 | Kennedy Joseph T (General Counsel) | Option Ex | 117,438 | .00 | 0 |
2016-01-31 | Ketchum Steven B (Chief Scientific Officer) | Option Ex | 117,438 | .00 | 0 |
2016-01-31 | Thero John F (President and CEO) | Option Ex | 429,500 | .00 | 0 |
2015-12-31 | Kennedy Joseph T (General Counsel) | Option Ex | 53,438 | .00 | 0 |
2015-12-31 | Thero John F (President and CEO) | Option Ex | 37,500 | .00 | 0 |
2015-10-05 | Kennedy Joseph T (General Counsel) | Option Ex | 6,250 | .00 | 0 |
2015-09-30 | Kennedy Joseph T (General Counsel) | Option Ex | 47,188 | .00 | 0 |
2015-09-30 | Thero John F (President and CEO) | Option Ex | 37,500 | .00 | 0 |
2015-08-11 | Thero John F (President and CEO) | Buy | 20,000 | 2.35 | 47,000 |
2015-01-31 | Farrell Michael James (VP, Finance) | Option Ex | 6,500 | .00 | 0 |
2015-01-31 | Kennedy Joseph T (Senior VP and General Counsel) | Option Ex | 56,500 | .00 | 0 |
2015-01-31 | Ketchum Steven B (President of R&D, SVP) | Option Ex | 56,500 | .00 | 0 |
2015-01-31 | Thero John F (President, Chief Exec. Officer) | Option Ex | 169,500 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of AMRN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amarin Corp Plc\uk (symbol AMRN, CIK number 897448) see the Securities and Exchange Commission (SEC) website.